HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Rose Sheet

Executive Summary

Parlux sales up in Q3: Roughly one week after announced resignation of Chairman and CEO Neil J. Katz "due to philosophical differences regarding the future of the company," Ft. Lauderdale, Fla.-based fragrance marketer books 6% increase in fiscal third-quarter sales to $50.3 mil., led by Queen Latifah and Marc Ecko scents. However, firm experienced a loss of $5.4 mil. for the quarter, compared with a $4.5 mil. loss in the comparable period of last year. Losses were attributed to "heavy investment" in U.S. department stores and lower consumer spending. Department store sales of its fragrances were down 30% in Q3, firm says. Parlux's board of directors has appointed company founder Frederick E. Purches chairman and interim CEO

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016736

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel